Reversing “Long COVID-19” Symptoms

Pilot studies indicate that stimulating the vagus nerve reduces the burden of covid-19.

During the pandemic the FDA granted emergency use authorization (EUA) for a handheld, noninvasive vagus nerve stimulator to treat COVID-19 patients with asthma-related breathing difficulties and reduced airflow.

These advanced neuromodulation devices stimulate the vagus nerve providing significant advantages to the use of traditional drugs such as being able to receive treatments at home, at much lower costs and with no harmful side effects.